Government removes ban on export of Paracetamol API

▴ Government removes ban on export of Paracetamol API
With restrictions on export relaxed government urges exporters for quality products

Government today removed restrictions on the export of paracetamol APIs. The Directorate General of Foreign Trade has issued a notification in this regard.

Export curbs were imposed on paracetamol and formulations made from the compound in March by the government to shore up domestic supplies amid the coronavirus pandemic.In April, the government had removed the curbs on shipments of formulations made from paracetamol. Now, it has removed restrictions on paracetamol APIs also. API is the active ingredient that is present in medicine.

Meanwhile, Commerce and Industry Minister Piyush Goyal has called upon the exporters to be more competitive and provide quality products to the world. Mr Goyal said this while addressing the Digital Summit on Exports organized by the Confederation of Indian Industry (CII)through video- conferencing.

The MInister identified three important ways to increase India’s exports-reviving manufacturing, diversifying the exports basket and finding newer and more accepting markets. Mr Goyal emphasized that the diversification of exports, in addition to consolidating current areas of strength, is necessary for country's economy to grow. He stated that India has a huge opportunity to promote indigenous production in auto component sector, furniture, air conditioners, and others.

He said, in the IT related service, the world recognizes the Indian expertise and prowess, and hence the government has asked the NASSCOM to target for 500 billion dollar export in the sector in next five years.

He said, Atmanirbhar Bharat is not just about greater self-reliance, but also engaging with the world from a position of strength. He said that India should be seen as a dependable partner and reliable friend in the world market, particularly when the global supply chains are undergoing rejig.

Tags : #Paracetamol #API #PharmaNews #PiyushGoyal

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024